Matches in Nanopublications for { ?s ?p "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- NP781406.RAVhq4xiZUuv4-6p97wdIW7Tvw8eyXAZLOrqNuHjXDGyg130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781406.RAVhq4xiZUuv4-6p97wdIW7Tvw8eyXAZLOrqNuHjXDGyg130_provenance.
- NP873345.RARCxMFJsgVJPMOFSUCkOzzsEZlA5q3UE6rLc2eZtqepw130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873345.RARCxMFJsgVJPMOFSUCkOzzsEZlA5q3UE6rLc2eZtqepw130_provenance.
- NP978501.RAdFCxr_Z-CdXDG6ebRXYd2bSGE-K1Yp7cHJW01p6DYLY130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978501.RAdFCxr_Z-CdXDG6ebRXYd2bSGE-K1Yp7cHJW01p6DYLY130_provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP781610.RAg-FeDS0yoECye3JAstkyDWqyXpImpFN2wPiM1VU36P4130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781610.RAg-FeDS0yoECye3JAstkyDWqyXpImpFN2wPiM1VU36P4130_provenance.
- NP354211.RAdcHZPu-1UA-5DWwkhPPyDTYyN3sx8X2zNEFdMot1NIk130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354211.RAdcHZPu-1UA-5DWwkhPPyDTYyN3sx8X2zNEFdMot1NIk130_provenance.
- NP354212.RAQ_6iPz3r2OUE-TXtCjtmN2hBA1TpXyQURAPPBNUyNy8130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354212.RAQ_6iPz3r2OUE-TXtCjtmN2hBA1TpXyQURAPPBNUyNy8130_provenance.
- NP354213.RAblVMVtoP2qO2o0fbuQf0SLHvKnorhmELWJbXhifg8F4130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354213.RAblVMVtoP2qO2o0fbuQf0SLHvKnorhmELWJbXhifg8F4130_provenance.
- NP354214.RAW9ZJr6lw7hmBin1EerEX3Jrs_NmCzRUldFIUCuRdONU130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354214.RAW9ZJr6lw7hmBin1EerEX3Jrs_NmCzRUldFIUCuRdONU130_provenance.
- NP873166.RABGvgZiR1zs5JNwol8AnwaxbBNU0ec8uswrV5cGZJRwo130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873166.RABGvgZiR1zs5JNwol8AnwaxbBNU0ec8uswrV5cGZJRwo130_provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP354206.RAtcJOgyfeC_n3vnYQWv0VTgeUpDdnry8TfYollP7jO1s130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354206.RAtcJOgyfeC_n3vnYQWv0VTgeUpDdnry8TfYollP7jO1s130_provenance.
- NP354210.RAvatmaS1gd_Djov-NT9EMQAX2wnT7hYL5Q_x81aQOIbc130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354210.RAvatmaS1gd_Djov-NT9EMQAX2wnT7hYL5Q_x81aQOIbc130_provenance.
- NP914233.RAm5SIlbRL8OKUMubBpnzD8QTIrU56JazqkUWla0cUO60130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914233.RAm5SIlbRL8OKUMubBpnzD8QTIrU56JazqkUWla0cUO60130_provenance.
- NP605961.RAxvxg51Xi-xm06ktX7sC-DavnCjKxbAg7xXieNHt5F5Q130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605961.RAxvxg51Xi-xm06ktX7sC-DavnCjKxbAg7xXieNHt5F5Q130_provenance.
- NP606179.RAzZJ23tAnp7NLigQKHsa5Ct_AaI3bFXnCV45ELTBDrc0130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606179.RAzZJ23tAnp7NLigQKHsa5Ct_AaI3bFXnCV45ELTBDrc0130_provenance.
- NP354207.RALiqO3feBMZfsR24iLYLFfz0C6uP8vhvcah6LaOUQz-8130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354207.RALiqO3feBMZfsR24iLYLFfz0C6uP8vhvcah6LaOUQz-8130_provenance.
- NP978701.RAJUQCmeA1zn6Nd0u3YlXOzSh4PREVGURlsK2P2oBSDNg130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978701.RAJUQCmeA1zn6Nd0u3YlXOzSh4PREVGURlsK2P2oBSDNg130_provenance.
- NP354208.RA67K-xz8AToDikE3pk3nrpewGejGmlNCEswYLWphbjhA130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354208.RA67K-xz8AToDikE3pk3nrpewGejGmlNCEswYLWphbjhA130_provenance.
- NP354209.RA7_BanEz6zS5yVKY6TChpnwZhUQ6xBuJyjle83FKWRq4130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354209.RA7_BanEz6zS5yVKY6TChpnwZhUQ6xBuJyjle83FKWRq4130_provenance.
- NP354215.RA2lQao4s0Ej_oq3pQhrxmuRA5m842U_zL_Q7oU5YwdvE130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354215.RA2lQao4s0Ej_oq3pQhrxmuRA5m842U_zL_Q7oU5YwdvE130_provenance.
- NP913992.RA1TL3L3JW1YAl6iklLt3JDeMRXWhVDu4ltIoIRuNlF5g130_assertion description "[The median latent period from achievement of complete remission (CR) of APL to diagnosis of t-MDS or t-AML was 34 (25-40) months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913992.RA1TL3L3JW1YAl6iklLt3JDeMRXWhVDu4ltIoIRuNlF5g130_provenance.